581 related articles for article (PubMed ID: 8981119)
1. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
[TBL] [Abstract][Full Text] [Related]
2. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
[TBL] [Abstract][Full Text] [Related]
3. Controlled ovarian stimulation using highly purified FSH results in a lower serum oestradiol profile in the follicular phase as compared with HMG.
Fried G; Harlin J; Csemiczky G; Wramsby H
Hum Reprod; 1996 Mar; 11(3):474-7. PubMed ID: 8731179
[TBL] [Abstract][Full Text] [Related]
4. Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination.
Mercan R; Mayer JF; Walker D; Jones S; Oehninger S; Toner JP; Muasher SJ
Hum Reprod; 1997 Sep; 12(9):1886-9. PubMed ID: 9363700
[TBL] [Abstract][Full Text] [Related]
5. [A randomized, controlled trial comparing follicle stimulating hormone (FSH) to human menopausal gonadotropin (hMG) in fertilization in vitro].
Daya S; Gumby J; Hughes EG; Collins JA; Sagle MA
Contracept Fertil Sex; 1995 Dec; 23(12):766-71. PubMed ID: 8556078
[TBL] [Abstract][Full Text] [Related]
6. Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin.
Imthurn B; Macas E; Rosselli M; Keller PJ
Hum Reprod; 1996 Nov; 11(11):2387-91. PubMed ID: 8981116
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of follicle stimulating hormone versus human menopausal gonadotrophin in in-vitro fertilization.
Daya S; Gunby J; Hughes EG; Collins JA; Sagle MA
Hum Reprod; 1995 Jun; 10(6):1392-6. PubMed ID: 7593503
[TBL] [Abstract][Full Text] [Related]
8. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists.
Frydman R; Howles CM; Truong F
Hum Reprod; 2000 Mar; 15(3):520-5. PubMed ID: 10686190
[TBL] [Abstract][Full Text] [Related]
10. A prospective comparative study on IVF outcomes with either purified FSH or human menopausal gonadotrophin in downregulated normogonadotrophic women.
Ismail AF; Hesham AI; Salah Z; Khaled M; Fouad N; Ashraf N; Hatem S; Hamdi B
Gynecol Obstet Invest; 2002; 53(4):220-3. PubMed ID: 12186987
[TBL] [Abstract][Full Text] [Related]
11. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
12. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization.
Tsai HD; Chen CM; Lo HY; Chang CC
Hum Reprod; 1995 Nov; 10(11):2909-12. PubMed ID: 8747042
[TBL] [Abstract][Full Text] [Related]
14. A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation programme.
Söderström-Anttila V; Foudila T; Hovatta O
Hum Reprod; 1996 Sep; 11(9):1864-70. PubMed ID: 8921055
[TBL] [Abstract][Full Text] [Related]
15. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
[TBL] [Abstract][Full Text] [Related]
16. Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles.
Platteau P; Nyboe Andersen A; Loft A; Smitz J; Danglas P; Devroey P
Reprod Biomed Online; 2008 Aug; 17(2):190-8. PubMed ID: 18681992
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques.
Bergh C; Howles CM; Borg K; Hamberger L; Josefsson B; Nilsson L; Wikland M
Hum Reprod; 1997 Oct; 12(10):2133-9. PubMed ID: 9402268
[TBL] [Abstract][Full Text] [Related]
18. In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review.
Trew GH; Brown AP; Gillard S; Blackmore S; Clewlow C; O'Donohoe P; Wasiak R
Reprod Biol Endocrinol; 2010 Nov; 8():137. PubMed ID: 21059191
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin stimulation after pituitary desensitization with leuprolide acetate, comparison of FSH/hMG and hMG alone cycles--a study of 166 cases.
Hwang FR; Chang MY; Soong YK
Changgeng Yi Xue Za Zhi; 1993 Dec; 16(4):223-30. PubMed ID: 8313205
[TBL] [Abstract][Full Text] [Related]
20. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone.
Balasch J; Miró F; Burzaco I; Casamitjana R; Civico S; Ballescá JL; Puerto B; Vanrell JA
Hum Reprod; 1995 Jul; 10(7):1678-83. PubMed ID: 8582960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
